JP2016504922A5 - - Google Patents

Download PDF

Info

Publication number
JP2016504922A5
JP2016504922A5 JP2015555816A JP2015555816A JP2016504922A5 JP 2016504922 A5 JP2016504922 A5 JP 2016504922A5 JP 2015555816 A JP2015555816 A JP 2015555816A JP 2015555816 A JP2015555816 A JP 2015555816A JP 2016504922 A5 JP2016504922 A5 JP 2016504922A5
Authority
JP
Japan
Prior art keywords
seq
mar
tep
transgene
nucleic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015555816A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016504922A (ja
JP6563816B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2014/000100 external-priority patent/WO2014118619A2/en
Publication of JP2016504922A publication Critical patent/JP2016504922A/ja
Publication of JP2016504922A5 publication Critical patent/JP2016504922A5/ja
Application granted granted Critical
Publication of JP6563816B2 publication Critical patent/JP6563816B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015555816A 2013-02-01 2014-02-01 増強された導入遺伝子発現およびプロセシング Active JP6563816B2 (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201361759802P 2013-02-01 2013-02-01
US61/759,802 2013-02-01
US201361800244P 2013-03-15 2013-03-15
US61/800,244 2013-03-15
US201361806634P 2013-03-29 2013-03-29
US61/806,634 2013-03-29
PCT/IB2014/000100 WO2014118619A2 (en) 2013-02-01 2014-02-01 Enhanced transgene expression and processing

Publications (3)

Publication Number Publication Date
JP2016504922A JP2016504922A (ja) 2016-02-18
JP2016504922A5 true JP2016504922A5 (https=) 2017-02-16
JP6563816B2 JP6563816B2 (ja) 2019-08-21

Family

ID=50239688

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015555816A Active JP6563816B2 (ja) 2013-02-01 2014-02-01 増強された導入遺伝子発現およびプロセシング

Country Status (20)

Country Link
US (1) US11898154B2 (https=)
EP (2) EP3536797B1 (https=)
JP (1) JP6563816B2 (https=)
KR (1) KR102235603B1 (https=)
CN (2) CN105073995A (https=)
AU (2) AU2014210856B2 (https=)
CA (1) CA2898878C (https=)
DK (2) DK3536797T5 (https=)
ES (2) ES2717175T3 (https=)
FI (1) FI3536797T3 (https=)
HU (2) HUE061494T2 (https=)
IL (1) IL240198B (https=)
LT (1) LT2951309T (https=)
PL (2) PL3536797T3 (https=)
PT (2) PT2951309T (https=)
RU (1) RU2711505C9 (https=)
SG (2) SG11201505487UA (https=)
SI (1) SI2951309T1 (https=)
WO (1) WO2014118619A2 (https=)
ZA (1) ZA201506419B (https=)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109576265B (zh) * 2014-04-01 2020-08-28 三生国健药业(上海)股份有限公司 一种含mar核心片段的动物细胞表达载体
CN105154473B (zh) * 2015-09-30 2019-03-01 上海细胞治疗研究院 一种高效安全的转座子整合系统及其用途
WO2017061354A1 (ja) * 2015-10-06 2017-04-13 国立大学法人 岡山大学 遺伝子発現用カセット及びその産生物
JP2017070224A (ja) * 2015-10-06 2017-04-13 国立大学法人 岡山大学 遺伝子発現用カセット及びその産生物
JP6871679B2 (ja) * 2016-03-23 2021-05-12 国立大学法人 岡山大学 遺伝子発現用カセット及びその産生物
CN108473982A (zh) 2015-12-24 2018-08-31 思兰克斯有限公司 用于蛋白生产的改进的真核细胞及其制备方法
ITUA20161610A1 (it) * 2016-03-14 2017-09-14 Angela Anna Messina Composto peptidico farmacologicamente attivo, procedimento per la sua preparazione e suo uso.
EP3219803A1 (en) * 2016-03-15 2017-09-20 Max-Delbrück-Centrum für Molekulare Medizin Enhanced sleeping beauty transposons, kits and methods of transposition
EP3219800A1 (en) * 2016-03-15 2017-09-20 Max-Delbrück-Centrum Für Molekulare Medizin A transposon-based transfection system for primary cells
MX2018013499A (es) * 2016-05-03 2019-09-11 Lonza Ag Modulacion del metabolismo lipidico para la produccion de proteinas.
WO2018066492A1 (ja) * 2016-10-03 2018-04-12 第一三共株式会社 Hspa5遺伝子のプロモーター
AU2017378482B2 (en) 2016-12-16 2024-06-13 R&D Systems, Inc. Enhanced hAT family transposon-mediated gene transfer and associated compositions, systems, and methods
US11278570B2 (en) 2016-12-16 2022-03-22 B-Mogen Biotechnologies, Inc. Enhanced hAT family transposon-mediated gene transfer and associated compositions, systems, and methods
WO2018224162A1 (en) * 2017-06-09 2018-12-13 Biontech Rna Pharmaceuticals Gmbh Methods for characterizing loss of antigen presentation
KR102712841B1 (ko) * 2017-09-29 2024-10-04 (주)벳바젠 심부전의 예방 또는 치료용 약학적 조성물
CN109929839B (zh) * 2017-12-18 2021-02-12 华东师范大学 拆分型单碱基基因编辑系统及其应用
CN108504692B (zh) * 2018-03-26 2021-07-23 安徽大学 一种基因敲除cho细胞株的构建方法及其在治疗性重组蛋白表达中的应用
EP3794128A1 (en) * 2018-05-18 2021-03-24 Sorbonne Universite Molecular tools and methods for transgene integration and their transposition dependent expression
AU2019288669B2 (en) 2018-06-21 2025-06-26 R&D Systems, Inc. Enhanced hAT family transposon-mediated gene transfer and associated compositions, systems, and methods
RU2686102C1 (ru) * 2018-08-07 2019-04-24 Федеральное Государственное Бюджетное Учреждение Науки Институт Молекулярной Биологии Им. В.А. Энгельгардта Российской Академии Наук (Имб Ран) Рекомбинантный вектор для создания плазмидных генетических конструкций, обладающих повышенной длительностью экспрессии целевых генов
WO2020049106A1 (en) * 2018-09-05 2020-03-12 Max-Delbrück-Centrum Für Molekulare Medizin In Der Helmholtz-Gemeinschaft A method for engineering synthetic cis-regulatory dna
WO2020081537A1 (en) * 2018-10-16 2020-04-23 Texas Tech University System Method to express, purify, and biotinylate eukaryotic cell-derived major histocompatibility complexes
US20230193341A1 (en) 2018-10-24 2023-06-22 Selexis Sa Expression systems, recombinant cells and uses thereof
PT3894549T (pt) 2018-12-10 2024-10-16 Amgen Inc Transposase piggybac mutada
EP3902910A1 (en) * 2018-12-24 2021-11-03 Selexis S.A. Characterization and inactivation of endogenous retroviruses in chinese hamster ovary cells
WO2020152532A1 (en) 2019-01-23 2020-07-30 Enzyvant Therapeutics Gmbh Method of ameliorating a pro-inflammatory immunophenotype in farber disease subjects by repeated administration of a recombinant human acid ceramidase
IT201900002321A1 (it) * 2019-02-18 2020-08-18 Univ Degli Studi Padova Peptidi con attivita' antitumorale
WO2020198556A2 (en) * 2019-03-27 2020-10-01 Phoenix Tissue Repair, Inc. Systems and methods for producing collagen 7 compositions
CN110006866B (zh) * 2019-04-16 2022-04-22 杭州迈尔德生物科技有限公司 一种阿片类活性物质的通用检测方法及其检测试剂盒
WO2020228721A1 (en) * 2019-05-13 2020-11-19 Lin Mei Chun Method and kit for monitoring cancer
CA3154452A1 (en) * 2019-10-10 2021-04-15 The Regents Of The University Of California Methods to stabilize mammalian cells
IL270306A (en) 2019-10-30 2021-05-31 Yeda Res & Dev Prevention and treatment of pre-myeloid and myeloid malignancies
CN112813099A (zh) * 2019-11-15 2021-05-18 上海细胞治疗集团有限公司 一种在活化的t细胞中具有高活性的启动子
CN110863008B (zh) * 2019-11-22 2020-10-16 昆明学院 Mar序列调控弱启动子构建高效表达载体的方法
CA3164931A1 (en) 2019-12-24 2021-07-01 Selexis Sa Targeted integration in mammalian sequences enhancing gene expression
JP7483907B2 (ja) * 2020-02-19 2024-05-15 ウーシー バイオロジクス アイルランド リミテッド 強化された発現系及びその使用方法
CN111500629B (zh) * 2020-04-17 2021-11-19 安徽中盛溯源生物科技有限公司 一种高表达层粘连蛋白-511变体的方法及其应用
EP4149966A4 (en) * 2020-05-14 2024-08-07 Seattle Children's Hospital (DBA Seattle Children's Research Institute) DOUBLE PROMOTOR SYSTEMS
US12173304B2 (en) * 2020-07-08 2024-12-24 Neuracle Genetics Inc. Intron fragments
CN113881703B (zh) * 2021-10-11 2022-06-21 中国人民解放军军事科学院军事医学研究院 一种提高cho细胞同源重组效率的方法及其相关产品和应用
CN116440269B (zh) * 2022-01-10 2024-02-09 华中农业大学 Slc35a1基因作为靶点在防治猪流行性腹泻病中的应用
CN114958914B (zh) * 2022-06-06 2023-09-26 新乡医学院 一种人类及哺乳动物细胞附着体表达载体、构建方法和应用
CN115896227A (zh) * 2022-12-20 2023-04-04 西北农林科技大学 一种鉴定外源基因整合位点以增强转基因表达的方法
GB202305637D0 (en) 2023-04-17 2023-05-31 Macomics Ltd Transposons, vectors and genetically engineered cells

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5731178A (en) 1990-03-21 1998-03-24 Behringwerke Aktiengesellschaft Attachment-elements for stimulation of eukaryotic expression systems
JP3656277B2 (ja) * 1995-05-17 2005-06-08 味の素株式会社 組換えdna法によるトランスグルタミナーゼの効率的製造法
DK1395669T3 (da) 2001-01-26 2009-11-16 Selexis Sa Matriks bindingsregioner og fremgangsmåder til anvendelse af disse
US20040235011A1 (en) 2002-06-26 2004-11-25 Cooper Richard K. Production of multimeric proteins
WO2004065581A2 (en) * 2003-01-15 2004-08-05 Discovery Genomics, Inc. Transposon-insulator element delivery systems
US7244616B2 (en) * 2003-06-27 2007-07-17 Bayer Pharmaceuticals Corporation Use of molecular chaperones for the enhanced production of secreted, recombinant proteins in mammalian cells
WO2005040377A2 (en) 2003-10-24 2005-05-06 Selexis S.A. High efficiency gene transfer and expression in mammalian cells by a multiple transfection procedure of matrix attachment region sequences
ES2292271B1 (es) * 2004-05-20 2009-02-16 Proyecto De Biomedicina Cima, S.L. Un vector hibrido adenovirus-alfavirus para la administracion eficaz y expresion de genes terapeuticos en celulas tumorales.
MX2007015540A (es) * 2005-06-10 2008-03-07 Genentech Inc Mejora de la expresion de anticuerpos utilizando vectores que contienen elementos aislantes.
DK2205618T3 (en) 2007-09-26 2017-02-20 Intrexon Corp SYNTHETIC 5 'NON-TRANSLATED REGIONS, EXPRESSION VECTORS AND PROCEDURES FOR INCREASING TRANSGENIC EXPRESSION
US20090247609A1 (en) 2007-12-20 2009-10-01 Hitto Kaufmann Sm-protein based secretion engineering
WO2010008564A2 (en) * 2008-07-16 2010-01-21 Recombinetics Plaice dna transposon system
EP2417263B1 (en) * 2009-04-09 2015-09-23 ProteoVec Holding L.L.C. Production of proteins using transposon-based vectors
KR20120099376A (ko) 2009-09-18 2012-09-10 셀렉시스 에스. 에이. 강화된 전이 유전자 발현과 공정 방법 및 그 산물

Similar Documents

Publication Publication Date Title
JP2016504922A5 (https=)
US20250320527A1 (en) Dna editing using single-stranded dna
RU2015127667A (ru) Улучшенные экспрессия и процессинг трансгена
Grier et al. pEVL: a linear plasmid for generating mRNA IVT templates with extended encoded poly (A) sequences
ES2977547T3 (es) Métodos para romper la tolerancia inmunológica utilizando múltiples ARN guía
CN110114461A (zh) 新型crispr酶和系统
US20200340012A1 (en) Crispr-cas genome engineering via a modular aav delivery system
ES2813609T3 (es) Polinucleótidos que codifican anticuerpos de roedores con idiotipos humanos y animales que los contienen
CN107794272B (zh) 一种高特异性的crispr基因组编辑体系
CN106011104B (zh) 利用拆分Cas系统进行基因编辑和表达调控方法
Narayanavari et al. Sleeping Beauty transposition: from biology to applications
JP2018533966A5 (https=)
JP2011505835A5 (https=)
US20230345919A1 (en) Non-human animals comprising a humanized asgr1 locus
WO2015018331A1 (zh) 含基因工程抗体基因表达盒的微环dna重组母质粒、含该表达盒的微环dna及应用
CN102943092A (zh) 一种通用型PiggyBac转座子转基因载体及其制备方法
JP2024502847A (ja) 組換えゲノム、非ヒト哺乳動物細胞及びその産生方法と用途
CN103160534A (zh) 一种通用型牛β-酪蛋白位点基因打靶载体及其制备方法
JP2022033728A (ja) 改変細胞、調製方法、及び構築物
Yang et al. Transgenesis of Tol2-mediated seamlessly constructed BAC mammary gland expression vectors in Mus musculus
Wright et al. Loss of the methylarginine reader function of SND1 confers resistance to hepatocellular carcinoma
CN102121032A (zh) 利用pRC/CMV-EGFP质粒创制转绿色荧光蛋白基因叉尾斗鱼方法
Pavlovic et al. Generation of targeted overexpressing models by CRISPR/Cas9 and need of careful validation of your knock-in line obtained by nuclease genome editing
US20250332287A1 (en) Identification of tissue-specific extragenic safe harbors for gene therapy approaches
Chen et al. Production of porcine aminopeptidase N (pAPN) site‐specific edited pigs